桂格完膳營養素腫瘤配方
桂格完膳營養素腫瘤配方 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
- Registration number
- 0980406945
- Chinese name
- 桂格完膳營養素腫瘤配方
- English name
- QUAKER COMPLETE NUTRITION FOOD CACHEXIA FORMULA
- Type
- Special medical nutrition product
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- 佳格食品股份有限公司
- Form
- 液劑
- Origin
- 台灣
- Registration date
- 2009-12-21
- Published validity end
- 2027-12-31
This product is special medical nutrition. Food supplement rules do not determine its compliance as a food for special medical purposes.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| MALTODEXTRIN | MALTODEXTRIN | Maltodextrine |
| CORN SYRUP | CORN SYRUP | Not identified |
| CALCIUM CASEINATE | CALCIUM CASEINATE | Not identified |
| SUCROSE | SUCROSE | Not identified |
| CANOLA OIL | CANOLA OIL | Not identified |
| SUNFLOWER SEED OIL | SUNFLOWER SEED OIL | Not identified |
| FIBERSOL | FIBERSOL | Not identified |
| GLUTAMINE PEPTIDE | GLUTAMINE PEPTIDE | Not identified |
| MCT | MCT | Triglycérides à chaine moyenne |
| SOYBEAN OIL | SOYBEAN OIL | Not identified |
| WHEY PROTEIN CONCENTRATE | WHEY PROTEIN CONCENTRATE | Not identified |
| VITAMIN PREMIX | VITAMIN PREMIX | Not identified |
| POTASSIUM CITRATE | POTASSIUM CITRATE | Potassium |
| EMULSIFIER (MONO-DI-AND TRI-GLYCERIDES,MONO-AND DIGLYCERIDES,ETHOXYLATED) | EMULSIFIER (MONO-DI-AND TRI-GLYCERIDES,MONO-AND DIGLYCERIDES,ETHOXYLATED) | Not identified |
| FISH OIL POWDER | FISH OIL POWDER | Not identified |
| FLAVOR | FLAVOR | Not identified |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Not identified |
| ARGININE | ARGININE | Arginine |
| TRIMAGNESIUM PHOSPHATE | TRIMAGNESIUM PHOSPHATE | Magnésium |
| MINERAL PREMIX | MINERAL PREMIX | Not identified |
| SODIUM CITRATE | SODIUM CITRATE | Not identified |
| MAGNESIUM CARBONATE | MAGNESIUM CARBONATE | Magnésium |
| SOY PROTEIN ISOLATE | SOY PROTEIN ISOLATE | Not identified |
| INULIN | INULIN | Inuline |
| L-CARNITINE | L-CARNITINE | L-carnitine |
| NUCLEOTIDE PREMIX | NUCLEOTIDE PREMIX | Not identified |
| CARRAGEENAN | CARRAGEENAN | Not identified |
| DEIONIZED WATER | DEIONIZED WATER | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Product name
- 桂格完膳營養素腫瘤配方
- Product form
- 液劑
- Packaging
- 250.00000毫升;1500.00000毫升
- Active ingredients
- MALTODEXTRIN;CORN SYRUP;CALCIUM CASEINATE;SUCROSE;CANOLA OIL;SUNFLOWER SEED OIL;FIBERSOL;GLUTAMINE PEPTIDE;MCT;SOYBEAN OIL;WHEY PROTEIN CONCENTRATE;VITAMIN PREMIX;POTASSIUM CITRATE;EMULSIFIER (MONO-DI-AND TRI-GLYCERIDES,MONO-AND DIGLYCERIDES,ETHOXYLATED);FISH OIL POWDER;FLAVOR;SODIUM CHLORIDE;ARGININE;TRIMAGNESIUM PHOSPHATE;MINERAL PREMIX;SODIUM CITRATE;MAGNESIUM CARBONATE;SOY PROTEIN ISOLATE;INULIN;L-CARNITINE;NUCLEOTIDE PREMIX;CARRAGEENAN;DEIONIZED WATER
- Valid until
- 2027/12/31
- Registration number
- 0980406945
- Origin
- 台灣
- Licence holder
- 佳格食品股份有限公司
- Registration date
- 2009/12/21
- Published reference
- DHD09804069459
- Published English name
- QUAKER COMPLETE NUTRITION FOOD CACHEXIA FORMULA
Official source
View the official register, number 0980406945
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
Open Government Data License, version 1.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- ARGININE
Read the warning, when it applies and the studies cited
L-ARGININE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you are pregnant or breastfeeding.
Condition of application: Improvement in exercise capacity in individuals with stable CVD.
Ask a health care practitioner/health care provider/health care professional/doctor/ physician if your symptoms worsen.
Applies to products providing more than 0.42 g of L-Arginine, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you have a cardiovascular disease and are attempting an increase in physical activity (Doutreleau et al. 2010; Doutreleau et al. 2006; Schulman et al. 2006; Goldman and Ausiello 2004; Nagaya et al. 2001; Bednarz et al. 2000; Ceremużyński et al. 1997; Rector et al. 1996).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners (Huynh et al. 2002; Parker et al. 2002; Siani et al. 2000; Adams et al. 1995).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing more than 9 g of L-Arginine, per day.
Do not use if you have had a heart attack/myocardial infarction (Sun et al. 2009; Schulman et al. 2006; Bednarz et al. 2005).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Applies to products providing more than 9 g of L-Arginine, per day.
When using this product you may experience gastrointestinal discomfort/disturbances (Grimble 2007; Evans et al. 2004; IOM 2005; Clarkson et al. 1996).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- L-CARNITINE
Read the warning, when it applies and the studies cited
L-CARNITINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.